Filing Details
- Accession Number:
- 0001140361-17-010367
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-02 18:14:08
- Reporting Period:
- 2017-03-01
- Filing Date:
- 2017-03-02
- Accepted Time:
- 2017-03-02 18:14:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1247681 | Bryan V Lawlis | C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-03-01 | 7,500 | $17.33 | 21,360 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-03-01 | 7,500 | $95.00 | 13,860 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to buy) Common Stock | Disposition | 2017-03-01 | 7,500 | $0.00 | 7,500 | $17.33 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2007-12-07 | 2017-06-06 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to a 10b5-1 trading plan executed on June 6, 2016.
- All shares were sold at the same price.
- Original option grant vests 6/48ths on December 7, 2007, and 1/48th on the 7th day of every month thereafter
- Reflects the number of stock options that remain outstanding from this specific stock grant following the reported transaction.
Billionaire Hedge Funds
